Technical Analysis for NBIO - Nascent Biotech Inc

Grade Last Price % Change Price Change
grade C 0.159 0.00% 0.0000
NBIO closed unchanged on Thursday, January 23, 2020, on 58 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up
Historical NBIO trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction 0.00%
Stochastic Reached Overbought Strength 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Narrow Range Bar Range Contraction 6.00%
Wide Bands Range Expansion 6.00%
Gapped Down Weakness 6.00%
Older signals for NBIO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Nascent Biotech Inc. is a clinical-stage biopharmaceutical company that develops monoclonal antibodies for the treatment of various forms of cancer. The Company is engaged in the research and development of the antibodies for control of brain and pancreatic cancer in humans. The Company focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The Company owns the license rights to a drug candidate, pritumumab, which it is developing. The Company is primarily focused on developing pritumumab for the treatment of patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma. Pritumumab is a monoclonal antibody. The Company has not generated revenues.
Medicine Cancer Biopharmaceutical Clinical Medicine Drugs Treatment Of Cancer Antibodies Monoclonal Antibodies Glioblastoma Targeted Therapy Anogen Treatment Of Various Forms Of Cancer

Is NBIO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News


Indicator Value
52 Week High 0.77
52 Week Low 0.052
Average Volume 11,978
200-Day Moving Average 0.1680
50-Day Moving Average 0.1315
20-Day Moving Average 0.1328
10-Day Moving Average 0.1488
Average True Range 0.0199
ADX 22.92
+DI 41.6876
-DI 22.4776
Chandelier Exit (Long, 3 ATRs ) 0.1203
Chandelier Exit (Short, 3 ATRs ) 0.1117
Upper Bollinger Band 0.1782
Lower Bollinger Band 0.0874
Percent B (%b) 0.79
BandWidth 68.3735
MACD Line 0.0075
MACD Signal Line 0.0033
MACD Histogram 0.0043
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1590
Resistance 3 (R3) 0.1590 0.1590 0.1590
Resistance 2 (R2) 0.1590 0.1590 0.1590 0.1590
Resistance 1 (R1) 0.1590 0.1590 0.1590 0.1590 0.1590
Pivot Point 0.1590 0.1590 0.1590 0.1590 0.1590
Support 1 (S1) 0.1590 0.1590 0.1590 0.1590 0.1590
Support 2 (S2) 0.1590 0.1590 0.1590 0.1590
Support 3 (S3) 0.1590 0.1590 0.1590
Support 4 (S4) 0.1590